C.V.: Beda M. Stadler page 28PatentsP-1.Kricek F., Stadler B.M., Rudolf M., Ruf. Immunogene Peptidmimotope zur Herstellung einer Vakzine für dieTherapie und Prophylaxe allergischer Erkrankungen. Erfindungsmeldung SW632. SandozForschungszentrum Wien. 5. 12. 1995.P-2.Miescher S., Stadler, B.M. Vogel.M. Morell A. Polypeptides capable <strong>of</strong> forming antigen binding structures withspecificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use.European Patent 96810421.6-2116. Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK, <strong>Bern</strong>. 24.6. 1996.P-3.Kricek; Franz (Biedermannsdorf, AT); Stadler; Beda (<strong>Bern</strong>, CH) Title: Peptide immunogens for vaccinationagainst and treatment <strong>of</strong> allergy United States Patent: 6,610,297 Issued: August 26, 2003 Inventors:Assignee: Novartis AG (Basel, CH) Appl. No.: 125641 Filed: August 21, 1998 PCT Filed: February 28,1997 PCT NO: PCT/EP97/01013 PCT PUB.NO.: WO97/31948 PCT PUB. Date: September 4, 1997P-4.KRICEK FRANZ (AT); STADLER BEDA (CH) PEPTIDE IMMUNOGENS FOR VACCINATION AGAINSTAND TREATMENT OF ALLERGY Patent number: SI885244T Publication date: 2003-06-30 Applicant:NOVARTIS AG (CH) Classification: - international: C07K16/00; A61K39/395 - european: Applicationnumber: SI19970030490T 19970228 Priority number(s): WO1997EP01013 19970228; EP1997090513619970228; GB19960004412 19960301; GB19960017702 19960822P-5.KRICEK FRANZ (AT); STADLER BEDA (CH). PEPTIDE IMMUNOGENS FOR VACCINATION AGAINSTAND TREATMENT OF ALLERGY Patent number: CA2245497 Publication date: 1997-09-04 Applicant:NOVARTIS AG (CH) Classification: - international: C07K19/00; C07K16/00; C07K17/00; A61K39/385;C07K16/42; A61K39/44 - european: Application number: CA19972245497 19970228 Priority number(s):WO1997EP01013 19970228; GB19960004412 19960301; GB19960017702 19960822P-6.Miescher S., Vogel.M. Stadler, B.M. Morell A, Imboden Martin, Amstutz Hanspeter. Polypeptides capable <strong>of</strong>forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and theprocess for their preparation and use. World Patent (PCT) 97/49809. Rotkreuzstiftung ZentrallaboratoriumBlutspendedienst SRK, <strong>Bern</strong>. 31. 12. 1997.P-7.AMSTUTZ HANSPETER (KR); VOGEL MONIQUE (KR); IMBODEN MARTIN (KR); MIESCHER SYLVIA(KR); MORELL ANDREAS (KR); STADLER BEDA (KR) POLYPEPTIDES CAPABLE OF FORMINGANTIGEN BINDING STRUCTURES WITH SPECIFICITY FOR THE RHESUS D ANTIGENS, THE DNAENCODING THEM AND THE PROCESS. Patent number: KR2000022530 Publication date: 2000-04-25Applicant: ROTKREUZSTIFTUNG ZENTRALLAB Classification: - international: C12N15/13; C12N15/62;C07K16/34 - european: Application number: KR19980710975T 19981224 Priority number(s):EP19960810421 19960624(Also published as: WO9749809 (A1) TR9802692T (T2) RU2204602 (C2) AU722127 (B2))P-8.AMSTUTZ HANSPETER (CH); VOGEL MONIQUE (CH); IMBODEN MARTIN (CH); MIESCHER SYLVIA(CH); MORELL ANDREAS (CH); STADLER BEDA (CH). POLYPEPTIDES CAPABLE OF FORMINGANTIGEN BINDING STRUCTURES WITH SPECIFICITY FOR THE RHESUS D ANTIGENS, THE DNAENCODING THEM AND THE PROCESS. Patent number: EP0920509 Publication date: 1999-06-09 Inventor:AMSTUTZ HANSPETER (CH); VOGEL MONIQUE (CH); IMBODEN MARTIN (CH); MIESCHER SYLVIA(CH); MORELL ANDREAS (CH); STADLER BEDA (CH) Applicant: ROTKREUZSTIFTUNG ZENTRALLAB
C.V.: Beda M. Stadler page 29(CH) Classification: - international: C12N15/13; C12N15/62; C07K16/34; A61K39/395; G01N33/80 -european: Application number: EP19970929244 19970620 Priority number(s): EP19970929244 19970620;WO1997EP03253 19970620; EP19960810421 19960624P-9. Kricek F., Stadler B.M., Vogel, M. Recombinant Anti-Idiotypic Antibodies. Foreign filing specification -Case 4-30888/NFI 9925. Novartis Forschungsinstitut (NFI), Vienna. 12. 4. 2000.P-10.Stadler B.M., Vogel, M, Germond J.-E. and Fritsche R. Lactic acid bacteria as agents for treating andpreventing allergy. European Patent 01105138.0-2106 Société des Produits Nestlé S.A. Date <strong>of</strong> filing 02.03.2001. Patent Number: EP1239032. Publication date: 2002-09-11. Applicant(s): NESTLE SA (CH). RequestedPatent: Application Number: EP20010105138 20010302. Priority Number(s): EP20010105138 20010302 IPCClassification: C12N1/20; A61K39/395; A61P37/08; C07K16/42 EC Classification: C07K16/00;A23K1/00C2B; A23K1/18N; C07K16/42M10P-11.VOGEL MONIQUE; KRICEK FRANZ; STADLER BEDA Anti-idiotypic antibodies against antibodies whichinhibit the binding <strong>of</strong> immunoglobuline to its high affinity receptor. Patent number: ZA200107906 Publicationdate: 2003-06-26 Applicant: NOVARTIS AG Classification: - international: A61K; A61P; C07K; G01N -european: Application number: ZA20010007906 20010926 Priority number(s): GB19990008533 19990414(Also published as: WO0063252 (A1) EP1169353 (A1) US2002141989 (A1) TR200102877T (T2))P-12.KRICEK FRANZ (AT); STADLER BEDA (CH). PEPTID-IMMUNOGENE ZUR SCHUTZIMPFUNG GEGENUND BEHANDLUNG VON ALLERGIEN. Patent number: AT230417T Publication date: 2003-01-15 Applicant:NOVARTIS ERFIND VERWALT GMBH (AT) Classification: - international: C07K16/00; A61K39/395 -european: Application number: AT19970905136T 19970228 Priority number(s): WO1997EP0101319970228; GB19960004412 19960301; GB19960017702 19960822